The mechanisms by which prostanoids contribute to the maintenance of whole body 27 water homeostasis are complex and not fully understood. The present study demonstrates 28 that an EP3-dependent feedback mechanism contributes to the regulation of water 29 homeostasis under high salt conditions. Rats on a normal diet and tap water were placed in 30 metabolic cages and given either sulprostone (20 µg/kg/day) or vehicle for 3 days to activate 31 EP3 receptors in thick ascending limb (TAL). Treatment was continued for another 3 days in 32 rats given either 1% NaCl in the drinking water or tap water. Sulprostone decreased 33 expression of COX-2 expression by approximately 75% in TAL tubules from rats given 1% 34
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Abstract 26
The mechanisms by which prostanoids contribute to the maintenance of whole body 27 water homeostasis are complex and not fully understood. The present study demonstrates 28 that an EP3-dependent feedback mechanism contributes to the regulation of water 29 homeostasis under high salt conditions. Rats on a normal diet and tap water were placed in 30 metabolic cages and given either sulprostone (20 µg/kg/day) or vehicle for 3 days to activate 31 EP3 receptors in thick ascending limb (TAL). Treatment was continued for another 3 days in 32 rats given either 1% NaCl in the drinking water or tap water. Sulprostone decreased 33 expression of COX-2 expression by approximately 75% in TAL tubules from rats given 1% 34
NaCl concomitant with a ~60% inhibition of COX-2-dependent PGE 2 levels in the kidney. 35
Urine volume increased after ingestion of 1% NaCl, but was reduced ~40% by sulprostone. 36
In contrast, the highly selective EP3 receptor antagonist (L-798106, 100 µg/kg/day), which 37 increased COX-2 expression and renal PGE 2 production, increased urine volume in rats 38 given 1% NaCl. Sulprostone increased expression of AQP2 in inner medullary collecting duct 39 plasma membrane in association with an increase in phosphorylation at Ser269 and 40 decrease in Ser261 phosphorylation; antagonism of EP3 with L798106 reduced AQP2 41 expression. Thus, although acute activation of EP3 by PGE 2 in the TAL and collecting duct 42 inhibits NKCC2 and AQP2 activity, respectively, chronic activation of EP3 in vivo limits the 43 extent of COX-2-derived PGE 2 synthesis thereby mitigating the inhibitory effects of PGE 2 on 44 these transporters and decreasing urine volume. 45 INTRODUCTION4 may limit the extent of COX-2-dependent PGE 2 production by the TAL in response to 71 elevated NaCl levels (8) . 72 Although the vasopressin-mediated increase in water permeability along the collecting 73 duct is a major determinant of whole-body water balance, a role for PGE 2 via various EP 74 receptors may provide additional mechanisms that regulate water homeostasis (32). Studies 75 8
Measurement of PGE 2 -160
PGE 2 content in rat TAL tubules and OM tissues were determined by LC-MS-MS using 161 a modified method according to the previously published assay (43). Briefly, frozen OM 162 tissue were homogenized and extracted for prostaglandins, and quantified by LC-MS/MS. 163
Analysis of PGE2 levels in TAL tubules also was determined by using an enzyme 164 immunoassay kit (Cat.RPN22210; GE Healthcare) according to the manufacturer's 165 instructions. The data were normalized by protein amount, which was determined by a 166
Bradford protein assay (Bio-Rad, Hercules, CA). 167
168
Western blot analysis-169
Tissue was solubilized with Triton X-100 lysis buffer after protease inhibitors (Roche, 170 Mannheim, Germany) were added for COX-2. The tissue was homogenized in ice-cold 171 sucrose solution (250 mM sucrose, 10 mM triethanolamine, pH 7.6, containing 1 mg/ml 172 leupeptin, 0.1 mg/ml phenylmethylsulfonyl fluoride, and 1× HALT phosphatase inhibitor 173 cocktail, Pierce, Rockland, IL) for total AQP2, pS261-AQP2 and pS269-AQP2. Protein 174 samples were heated in boiling water with loading buffer and concentration determined with a 175
Bio-Rad protein assay kit (Hercules, CA). Equal amounts of protein were separated by SDS-176 PAGE and electrophoretically transferred to nitrocellulose membranes. Following blocking, 177 membranes were probed at 4°C overnight with appropriate primary antibodies, followed by 178 incubation with horseradish peroxidase (HRP)-conjugated secondary antibodies (Amersham9
Immunohistochemistry Analysis-184
The kidneys from rats were fixed by retrograde perfusion via the abdominal aorta with 185 3% paraformaldehyde in 0.1 M cacodylate buffer, pH 7.4, and then tissues were immersion 186 fixed in 4% paraformaldehyde for 24 h at room temperature and embedded in paraffin wax. 187
The paraffin-embedded tissues were cut into 3-µm sections on a rotary microtome (Leica 188
Microsystems, Herlev, Denmark). For the AQP2 assay, the sections were deparaffinated and 189 rehydrated. To expose antigens, kidney sections were boiled in a target retrieval solution (1 190 mmol/l Tris, pH 9.0 with 0.5 mM EGTA) for 10 min. After cooling, the nonspecific binding was 191 prevented by incubating the sections in 50 mM NH4Cl in PBS for 30 min, followed by 192 blocking in PBS containing 1% BSA, 0.05% saponin and 0.2% gelatin. Samples were 193 permeabilized in PBS plus 1% BSA, and 0.1% Triton X100 for 10 minutes; blocking was 
Statistics-202
All data are presented as mean ± SE. Statistical analyses were performed using one-203 way ANOVA followed by Tukey's multiple comparisons test and unpaired Student's t-test 204 using GraphPad Prism software (GraphPad Software Inc., San Diego, CA). Differences with 205 p<0.05 were considered statistically significant. 206
RESULTS
208
Selective activation of EP3 in the TAL inhibits COX-2 expression and PGE 2 synthesis 209
induced by HS: 210
We recently showed that COX-2 expression induced by Coxibs in the TAL is under the 211 control of an EP3-dependent feedback mechanism (41). Since the effects of EP3 activation 212 on COX-2 expression induced by other stimuli is not known, we determined if EP3 feedback 213 inhibition regulates COX-2 expression in the TAL induced by high salt intake. Rats were 214 pretreated with either vehicle or sulprostone for 3 days while ingesting a normal diet and tap 215 water, then given 1% NaCl in the drinking for 3 days while continuing to receive either vehicle 216 (DMSO) or sulprostone. Western blot analysis showed that sulprostone inhibits the increase 217 in COX-2 protein expression in mTAL tubules induced by 1% NaCl in the drinking water 218 (Figure 1 ). We previously showed that sulprostone alone had a negligible effect on COX-2 219 expression by Western analysis, EP3 receptors are expressed on the apical membrane of the 220 TAL, and that EP1 receptors are absent from this segment of the nephron (41). The 221 suppression of COX-2 protein expression via EP3 activation may involve a mechanism that 222 inhibits either COX-2 gene transcription or mRNA stability as the increase in COX-2 mRNA 223 induced by 1% NaCl in outer medulla (OM) and mTAL tubules was inhibited by sulprostone 224 (Figure 2 ). The decreases in COX-2 protein and mRNA levels were associated with a 225 simultaneous reduction in PGE 2 content in the OM and mTAL tubules from sulprostone-226 treated rats that consumed 1% NaCl compared to those consuming tap water (Figure 3) . 227
These findings suggest that EP3 receptor activation attenuates COX-2 expression and 228 activity induced by high NaCl intake, and are consistent with a COX-2-dependent increase in11 EP3 receptor modulation alters water excretion upon high salt intake: 232
As PGE 2 antagonizes the hydroosmotic effects of AVP, we determined if the decrease 233 in PGE 2 levels resulting from suppression of COX-2 by EP3 activation with sulprostone would 234 alter urinary water excretion. Rats were given vehicle, sulprostone, or the highly selective 235 EP3 antagonist, L-798106 for 3 days while ingesting a normal salt diet and water ad libitum; 236 each group was then given 1% NaCl in the drinking water for an additional 3 days. In rats 237 consuming 1% NaCl in the water drinking, sulprostone decreased urine volume compared to 238 vehicle-treated rats (Figure 4 ). The effect was evident 24 hr after rats were switched from tap 239 water to hypertonic saline and was sustained for the 3 days shown in Figure 4A and, in fact, 240 persisted for at least 10 days (not shown). The decrease in urine volume in sulprostone-241 treated rats also was associated with an increase in urine osmolality on days 1 and 3 ( Figure  242 4B). In contrast, treatment with L-798106 increased urine volume in rats given 1% NaCl 243 compared with vehicle-treated rats; the kinetics and duration of the effect were similar to that 244 observed with sulprostone ( Figure 5 ). No differences in urine volume were observed for rats 245 given vehicle, sulprostone, or L-798106 under normal salt conditions (Figures 4 and 5) . 246
There also were no differences in food intake between vehicle and drug-treated groups 247 receiving either tap water or 1% NaCl, however, changes in water intake paralleled changes 248 in urine output ( Figures 6A-D) . Neither sulprostone nor L798106 altered water intake and 249 urine output in rats ingesting tap water. In contrast, sulprostone decreased urine volume and 250 water intake ( Figures 6A and B) , while L798106 increased urine volume and water intake in 251 rats given 1% NaCl in the drinking water ( Figures 6C and D) . Collectively, the data indicate 252 that while modulation of EP3 does not affect water excretion under normal salt conditions, the 253 diuretic effect of PGE 2 to maintain water balance is influenced in a bi-functional manner by 254 the degree of EP3 activation in response to hypertonic saline intake.
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EP3 receptors modulate AQP2 expression in the inner medulla: 257
Water permeability and trafficking of the water channel AQP2, which plays a major role 258 in water reabsorption and urine excretion, are regulated by PGE 2 (31). Accordingly, effects of 259 the EP3/COX-2 negative feedback axis on AQP2 expression and cellular localization were 260 determined in rats given vehicle or sulprostone for 3 days while ingesting 1% NaCl in the 261 drinking water. Sulprostone increased inner medullary expression of both non-glycosylated 262 (29 kDa) and glycosylated (45 kDa) AQP2 compared with vehicle-treated rats ( Figure 7) . 263
Conversely, AQP2 expression was reduced by more than 50% in rats treated with the EP3 264 receptor antagonist L798106 (Figure 8 ). The nearly three-fold increase in AQP2 protein 265 expression was accompanied by a similar increase in AQP2 mRNA accumulation ( Figure  266 9A), suggesting that a mechanism involving increased gene transcription and/or mRNA 267 stability was initiated following EP3 activation in the context of hypertonic saline intake. As 268 glycosylation may be important for the exit of AQP2 from the Golgi complex and subsequent 269
targeting to the membrane, we evaluated the effects of sulprostone on AQP2 localization in 270 the inner medullary collecting duct (IMCD). Diffuse staining of AQP2 was observed in the 271 IMCD obtained from rats given 1% NaCl for three days and pretreated with vehicle ( Figure  272 9B, left panel). In contrast, the intracellular staining pattern in rats that received sulprostone 273 is consistent with enhanced expression at the plasma membrane ( Figure 9B , right panel). 274
Overall, the data are consistent with the notion that increased expression and function of 275 AQP2 in the collecting duct contribute to the antidiuretic effect of sulprostone and diuretic 276 effect of L798106 under high salt conditions. 277
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Effects of EP3/COX-2 negative feedback on site-specific phosphorylation of AQP2: 280 AQP2 accumulation at the plasma membrane is associated with increases in 281 phosphorylation of Ser269, which alter subsequent protein-protein interactions that reduce 282 internalization of AQP2 (24). Since PGE 2 can induce AQP2 internalization (26) and 283 sulprostone increased AQP2 abundance and decreased PGE 2 production, we evaluated 284 phosphorylation of AQP2 at Ser261 and Ser269 under high salt conditions. Phosphorylation 285 of AQP2 at Ser269 increased in inner medulla isolated from rats pretreated with sulprostone 286 for three days and ingesting 1% NaCl for an additional three days compared with vehicle-287 treated rats ( Figure 10A ). In contrast, there was a concomitant decrease in phosphorylation 288 of AQP2 at Ser261 in sulprostone-treated rats ingesting hypertonic saline ( Figure 10B ). 289
These data suggest that under high salt conditions, chronic activation of EP3 receptors can 290 modulate phosphorylation of AQP2, subsequent to AVP-induced Ser256 phosphorylation, at 291 Ser261 and Ser269 residues in a manner that promotes AQP2 trafficking to the apical 292 membrane, thereby mediating a decrease in water excretion. The present study was conducted to determine whether the feedback mechanism by 302 which EP3 receptors regulate COX-2-dependent PGE 2 production in the TAL was associated 303 with altered urine output under normal and high salt conditions. We demonstrated that 304 sulprostone inhibited COX-2 expression induced by high salt in the TAL concomitant with a 305 decrease in PGE 2 levels, indicating that activation of EP3 receptors downregulates COX-2-306 derived PGE 2 synthesis in this segment of the nephron. Conversely, COX-2-derived PGE 2 307 production in response to high salt conditions increases when EP3 receptors in the TAL are 308 blocked with L798106 (8). Accordingly, urine output decreased when EP3 were activated, 309
and increased subsequent to EP3 inhibition. Activation of EP3 under high salt conditions 310 increased the total expression and plasma membrane abundance of AQP2 in association 311 with an increase in its phosphorylation at Ser269 and decrease in phosphorylation at Ser261, 312 an effect that was reversed when EP3 receptors were blocked. The data suggest that EP3 313 feedback inhibition contributed to an increase in AQP2, which altered the excretion of an 314 appropriate water load in response to high salt intake. Collectively, these findings are 315 consistent with our previous study showing that the increase in PGE 2 synthesis induced by 316 high salt is regulated by EP3 receptor feedback inhibition, and supports the hypothesis that 317 renal production of this prostanoid is an important determinant of water excretion (8, 31) . 318
The observations in this study may, at first glance, appear counterintuitive as PGE 2 319 exhibits several actions that antagonize the effects of AVP (6, 11, 35) . Among several EP3 320 signaling pathways, acute G i -mediated inhibition of cAMP decreases NKCC2 activity in the 321 TAL and antagonizes AVP-dependent AQP2-dependent water reabsorption in the collecting 322 duct (27, 33). However, chronic regulation of these transporters via EP3 receptors, the15 expression of which is increased in response to hypertonic conditons, is subject to feedback 324 inhibition that limits the extent of COX-2-derived PGE 2 production (8, 17, 20) . Thus, the 325 short-term signaling events may be superseded by the feedback inhibition axis, which limits 326 the production of PGE 2 . Accordingly, when presented with high salt conditions in the context 327 of a coordinated induction of COX-2-derived PGE 2 synthesis and upregulation of EP3 in the 328 TAL, sulprostone mitigates the increase in PGE 2 required to offset AVP-dependent increases 329 in AQP2 expression and function (19). In the absence of PGE 2 , AQP2 expression and 330 phosphorylation at Ser269 increased along with trafficking to the plasma membrane and the 331 ability to reabsorb water. Similarly, treatment with a COX-2 inhibitor ameliorated lithium-332 induced nephrogenic diabetes insipidus by upregulating NKCC2 and AQP2 (19) . 333
Previous studies have noted the phenomenon of increased COX-2 protein expression 334 subsequent to COX inhibition in the kidney, however, neither the mechanism responsible for 335 the increase nor functional implications have been addressed (4, 7, 13, 30) . For instance, 336 increased COX-2 expression was observed in a study showing that COX-2 inhibition 337 prevented the downregulation of renal transport proteins after bilateral ureteral obstruction 338 (30). The present study considered the functional implications of COX-2 feedback inhibition 339 via the EP3-dependent mechanism that operates in response to COX-2 inhibition and high 340 salt intake (8, 41). Our recent studies showed that EP3, the predominant prostanoid receptor 341 expressed in the TAL, is expressed on the apical membrane under normal and high salt 342 conditions (8, 41). Thus, even though sulprostone acts as a dual EP3/EP1 agonist and has a 343 similar affinity as PGE 2 for these receptors (21, 37), the TAL does not express EP1, a finding 344 that is confirmed by observations showing functional effects via activation of EP3, but not 345 EP1, in the TAL (1, 41). The effects of PGE 2 on AQP2 also do not appear to be EP1-346 dependent since an EP1 antagonist had no effect on AVP-dependent AQP2 targeting, and16 EP1 receptor stimulation does not decrease AQP2 membrane targeting or water permeability 348 in the CD (32). In addition, PGE 2 inhibits the AVP-induced increase in water permeability in 349 inner medullary collecting ducts via EP1 receptors, an effect that would tend to increase urine 350 volume rather than decrease it as shown in response to sulprostone in the present study (25) . 351 As a complementary approach, we studied the contribution of the COX-2/PGE 2 /EP3 axis to 352 the regulation of urine output by using a highly selective EP3 receptor antagonist L-798106. for mediating the natriuretic actions of PGE 2 (3). We currently are determining whether the 360 effects of PGE 2 generated via the EP3/COX-2 feedback mechanism in the TAL exerts 361 paracrine effects on other nephron segments and/or if a similar feedback mechanism is 362 operative in the collecting duct. 363
Previous studies showed that basal water permeability is not affected by treatment 364 with sulprostone alone (12). In contrast, chronic treatment with sulprostone significantly 365 decreased urine output, COX-2 expression, and PGE 2 production in rats ingesting high salt, 366
suggesting that the natriuretic response that limits salt and water retention may have become 367 impaired and that EP3 receptor activation is participating in urine volume regulation under 368 these conditions. Expression and trafficking of AQP2 to the apical membrane in the 369 collecting duct is regulated by the increase of cyclic AMP (cAMP)-mediated signaling after 370 stimulation of vasopressin 2 receptors by AVP, leading to protein kinase A (PKA) activation.
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Subsequently, AQP2 is phosphorylated and redistributed to the plasma membrane from 372 intracellular vesicles after phosphorylation at Ser256 by PKA, which is necessary for AVP-373 mediated apical translocation (28). Phosphorylation of AQP2 at Ser261 and Ser269 also is 374 critical for AQP2 trafficking to the membrane and its overall function (15, 16, 39) . In the 375 present study we showed that chronic EP3 activation under high salt conditions was 376 associated with increased AQP2 phosphorylation at Ser269 and decreased phosphorylation 377 at Ser261. Phosphorylation of AQP2 at Ser269 depends on prior phosphorylation at Ser256 378 and was observed exclusively in the apical membrane of the collecting duct where it 379 enhances retention of AQP2 suggesting that activation of the EP3/COX-2/PGE 2 axis 380 facilitates AVP-mediated AQP2 trafficking by limiting renal PGE 2 production (14). While 381
Ser269 is the only phosphorylated form detected in the apical plasma membrane, AQP2 382 trafficking in response to AVP also is regulated by endocytosis and exocytosis, which help 383 determine its steady state abundance there (22, 29) . A decrease in AQP2 phosphorylation at 384
Ser261 in the present study suggests that phosphorylation at this site, which is associated 385 with a different distribution mechanism from total AQP2 as well as AQP2 phosphorylated at 386 Ser256, follows ubiquitination and endocytosis and may stabilize AQP2 ubiquitination and 387 intracellular localization (15, 39). Thus, sulprostone-mediated reduction in phosphorylation at 388 Ser261 is consistent with the steady-state redistribution of AQP2 from vesicles to the apical 389 membrane and a decrease in urine output (40). 390
Urinary volume and concentration are regulated primarily by AVP, yet PGE 2 plays an 391 important role by providing an alternative regulatory mechanism. EP3 contribute to the 392 maintenance of low urine osmolality under normal conditions and genetic deletion of EP3 393 revealed that compensatory mechanisms regulate urine osmolality in its absence (5).18 multifaceted effects of PGE 2 on water excretion by the kidney. The contribution of feedback 396 regulation of COX-2 by EP3 provides an additional layer of functional regulation and may 397 supplant the short-term regulatory effects attributed to PGE 2 in isolated cell and tubule 398 preparations. For instance, it is interesting to speculate that the paradoxical increase in PGE 2 399 production in P2Y2 deficient mice subjected to a model of lithium-induced polyuria and 400 associated with a decrease in EP3 expression is related to increases in COX-2-derived PGE 2 401 synthesis observed by pharmacological inhibition of EP3 (8, 41, 45) . The present study 402
indicates that alterations in EP3 activation status affects water balance in response to high 403 salt intake and suggests that additional roles for the COX-2/PGE 2 /EP3 axis may be revealed 404 in clinical disorders of water balance. COX-2 mRNA increased in response to 1% NaCl compared to control in outer medulla 556 and TAL tubules. Treatment with sulprostone (sulp) decreased COX-2 mRNA levels induced 557 by 1% NaCl, suggesting that activation of EP3 exerts a negative feedback effect on COX-2. 558
The data are presented as mean ± SE; n=3. Inner medulla was isolated from vehicle or sulprostone-treated rats given 1% 611 NaCl in the drinking water for 3 days. Western blot analysis was performed using phospho- 
